415 related articles for article (PubMed ID: 26970094)
1. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
2. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.
Makhaeva GF; Rudakova EV; Hein ND; Serebryakova OG; Kovaleva NV; Boltneva NP; Fink JK; Richardson RJ
J Appl Toxicol; 2014 Dec; 34(12):1426-35. PubMed ID: 24395470
[TBL] [Abstract][Full Text] [Related]
3. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ
J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates.
Malygin VV; Sokolov VB; Richardson RJ; Makhaeva GF
J Toxicol Environ Health A; 2003 Apr; 66(7):611-25. PubMed ID: 12746136
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
[TBL] [Abstract][Full Text] [Related]
6. Relative potencies of the four stereoisomers of isomalathion for inhibition of hen brain acetylcholinesterase and neurotoxic esterase in vitro.
Jianmongkol S; Berkman CE; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 1996 Aug; 139(2):342-8. PubMed ID: 8806851
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in vivo and kinetics of inhibition by chlorpyrifos oxon in vitro: application to assessment of neuropathic risk.
Richardson RJ; Moore TB; Kayyali US; Fowke JH; Randall JC
Fundam Appl Toxicol; 1993 Apr; 20(3):273-9. PubMed ID: 7684990
[TBL] [Abstract][Full Text] [Related]
8. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
Funk KA; Liu CH; Higgins RJ; Wilson BW
Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
[TBL] [Abstract][Full Text] [Related]
9. Preliminary characterisation of an in vitro paradigm for the study of the delayed effects of organophosphorus compounds: hen embryo brain spheroids.
Sales KM; Kingston ST; Doyle KM; Purcell WM
Toxicology; 2004 Feb; 195(2-3):187-202. PubMed ID: 14751674
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity.
Ehrich M; Correll L; Veronesi B
Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605
[TBL] [Abstract][Full Text] [Related]
11. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon.
Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC
Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916
[TBL] [Abstract][Full Text] [Related]
12. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress.
Makhaeva GF; Malygin VV; Strakhova NN; Sigolaeva LV; Sokolovskaya LG; Eremenko AV; Kurochkin IN; Richardson RJ
Hum Exp Toxicol; 2007 Apr; 26(4):273-82. PubMed ID: 17615108
[TBL] [Abstract][Full Text] [Related]
13. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.
Kropp TJ; Richardson RJ
J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540
[TBL] [Abstract][Full Text] [Related]
14. In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate.
Fernandes LS; Emerick GL; dos Santos NA; de Paula ES; Barbosa F; dos Santos AC
Toxicol In Vitro; 2015 Apr; 29(3):522-8. PubMed ID: 25596135
[TBL] [Abstract][Full Text] [Related]
15. Interactions in vitro of some organophosphoramidates with neuropathy target esterase and acetylcholinesterase of hen brain.
Jokanovic M; Johnson MK
J Biochem Toxicol; 1993 Mar; 8(1):19-31. PubMed ID: 8492300
[TBL] [Abstract][Full Text] [Related]
16. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN).
Pope CN; Tanaka D; Padilla S
Chem Biol Interact; 1993 Jun; 87(1-3):395-406. PubMed ID: 8343996
[TBL] [Abstract][Full Text] [Related]
17. Esterase profiles of organophosphorus compounds in vitro predict their behavior in vivo.
Makhaeva GF; Rudakova EV; Serebryakova OG; Aksinenko AY; Lushchekina SV; Bachurin SO; Richardson RJ
Chem Biol Interact; 2016 Nov; 259(Pt B):332-342. PubMed ID: 27154493
[TBL] [Abstract][Full Text] [Related]
18. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
Wu SY; Casida JE
Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
[TBL] [Abstract][Full Text] [Related]
19. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
Sogorb MA; González-González I; Pamies D; Vilanova E
Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
[TBL] [Abstract][Full Text] [Related]
20. QSAR for the organophosphate-induced inhibition and 'aging' of the enzyme neuropathy target esterase (NTE).
Singh AK
SAR QSAR Environ Res; 2001; 12(3):275-95. PubMed ID: 11696925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
